Middle East and Africa pediatric healthcare market is growing steadily. Pediatric healthcare is related to the health of the children, infants, and adolescents. Pediatrics not only deals with the physical and mental health but also social health of children. Rising diseases in infants and children are driving the growth for pediatric healthcare market. According to UNICEF, while the child mortality rate has been dropping in the Middle East since 2000, 415,000 children in the region continue to die every year before their fifth birthdate. Increasing short term & chronic diseases, developing healthcare infrastructure and facilities are leading the growth for pediatric healthcare in Middle East and Africa region. Middle East and Africa region which comprise about 2% of global healthcare expenditure which expected to grow continuously. Technological advancement and government initiatives to improve healthcare sector are driving the growth for pediatric healthcare in Middle East and Africa. Market for pediatric healthcare in Middle East and Africa was about US$ 48 billion in 2016 and expected to reach US$ 63.6 billion by 2023 at CAGR of 4.1%.
Middle East and Africa Pediatric healthcare Market has been segmented as follows:
• On the basis of type of diseases which comprise Short term diseases, chronic diseases, and others.
• On the basis of Therapeutics which comprise cardiology, allergy and immunology, gastroenterology, infectious disease, and others.
• On the basis of treatment it segmented into medication, surgery, and others
Request a Sample Report @ https://www.marketresearchfuture.com/sample_request/2778
Study Objective of Middle East and Africa Pediatric Healthcare Market
• To provide detailed analysis of the market structure along with forecast for the next 7 years of the various segments and sub-segments of the Middle East and Africa Pediatric healthcare Market
• To provide insights about factors affecting the market growth
• To analyze the Pediatric healthcare Market based on various factors such as price analysis, supply chain analysis, Porters Five Forces analysis etc.
• To provide historical and forecast revenue of the market segments and sub-segments with respect to two main geographies and their countries
• To provide country level analysis of the market with respect to the current market size and future prospective
• To provide country level analysis of the market for segments by type of diseases, by therapeutics, by treatment, and its sub-segments.
• To provide overview of key players and their strategic profiling in the market, comprehensively analyzing their core competencies, and drawing a competitive landscape for the market
• To track and analyze competitive developments such as joint ventures, strategic alliances, mergers and acquisitions, new product developments, and research and developments in the Middle East and Africa Pediatric healthcare Market
Browse Report Details @ https://www.marketresearchfuture.com/reports/pediatric-healthcare-market-2778
Some of the key players in this market are:
• Novartis AG (Switzerland)
• AstraZeneca (UK)
• Janssen Global Services
• LLC (Belgium)
• Eli Lilly and Company (US)
• Bristol-Myers Squibb Company (US)
• AMMT (Dubai)
• King Faisal Specialist Hospital and Research Centre (Saudi Arabia)
• VPS Healthcare (UAE)
• Hospitals and Clinics
• Pediatric healthcare devices manufacturers and suppliers
• Government and Independent Regulatory Authorities
• Research laboratories
• Research and Development (R&D) Companies
• Market Research and Consulting Service Providers
• Medical Research Laboratories
• Potential Investors
Regional Analysis of Middle East and Africa Pediatric Healthcare Market:
Considering the scenario of the Middle East and Africa market, UAE region is believed to be the largest market for Middle-East and Africa Pediatric healthcare. Moreover, Saudi Arabia market is also growing and second largest market for pediatric healthcare. On the other hand, Egypt market is expected to grow at the steady pace in the Middle-East and Pediatric healthcare during the forecasted period. Rest of the Middle East and Africa region is likely to have a limited but steady growth in the market.